Startups channel feed – Endpoints News

Startups channel feed

RNA editing startup raises $155M to bring liver and lung disease therapy into clinic

Last month

Inspirna, which was preparing for a Phase 3 cancer trial, has folded

Last month

Alphabet’s Isomorphic Labs raises $600M in biotech’s largest round of 2025

Last month

Exclusive: SV Health debuts Parkinson's biotech with backing from AbbVie and others

Last month

Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025

Last month

Galatea Bio gets $25M to map genetic diversity of 10 million people, help pharma create new medicines

Last month

Aurion CEO is out as Alcon takes majority stake in cell therapy startup

Last month

ElevateBio trims workforce by 17%

2 months ago

Lyndra Therapeutics to wind down amid funding hurdles for long-acting drug technology

2 months ago

Ophthalmology startup Character Biosciences gets $93M for genetics-based approach

2 months ago

Another immunology biotech emerges as Hillstar takes flight with $67M

2 months ago

Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disorders

2 months ago

Belgian biotech Augustine gets $85M for neuro and cardiometabolic pills

2 months ago

SV Health Investors nabs $250M to fund dementia-focused biotechs

2 months ago

Ascendis’ China joint venture, Visen Pharmaceuticals, prices $86M Hong Kong IPO

2 months ago

Flagship's Ampersand gets Eli Lilly's support in $65M Series B

2 months ago

CRISPR company Arbor raises $73.9M to test therapy in clinical trials

2 months ago

Sofinnova Partners lands €165M, backed by big pharma, to build early-stage biotechs in Europe

2 months ago

George Church spinout developing genomically recoded organisms cuts most employees

2 months ago

Curevo gets $110M for a shot against Shingrix, gets Moncef Slaoui and Tal Zaks on board

2 months ago

Otsuka's Taiho buys Swiss startup Araris with three ADCs nearing the clinic

2 months ago

HC Bioscience, a tRNA biotech backed by ARCH and Takeda, shuts down

2 months ago

Latigo collects $150M to get non-opioid data to compete with Vertex in acute pain

2 months ago

Lilly-backed UK biotech raises $72M to advance its antibody approach

2 months ago

First page Previous page 1 234 5 6 Next page Last page